International AIDS Society Conference

July 17-20, 2011 - Rome, Italy

Back IAS 2011

IAS 2011: iPrEx Shows PrEP is Durable [VIDEO]

The effectiveness of biomedical approaches to prevent HIV infection was a key theme of the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011), held July 17-20, 2011, in Rome.

Among the major studies presented, Robert Grant from the Gladstone Institute of the University of California at San Francisco described final data from the iPrEx trial, which showed that pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine (Truvada) reduced new HIV infections by 42% overall, and by more than 90% among people who demonstrated good adherence.alt

Read more:

IAS 2011: New Integrase Inhibitor Dolutegravir Looks Potent and Well-tolerated

The next-generation HIV integrase inhibitor dolutegravir (S/GSK1349572) suppressed HIV viral load as well as efavirenz (Sustiva) but caused fewer side effects in a study of treatment-naive patients, researchers reported at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) last week in Rome. alt

Read more:

IAS 2011: Doubt Remains if HIV Therapy Increases the Risk of Fragility Fractures

The relationship between HIV therapy and fracture risk is far from straightforward, U.S. research presented to the International AIDS Society conference in Rome suggests.

Read more:

IAS 2011: Raltegravir Still Effective at 5 Years

The sole approved integrase inhibitor, raltegravir (Isentress), continues to keep HIV suppressed for nearly 5 years in patients starting treatment for the first time, according to astudy presented at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) last week in Rome.alt

Read more:

IAS 2011: HIV PrEP Effective for Heterosexuals, Discordant Couples

Two studies find that pre-exposure prophylaxis (PrEP) with tenofovir or tenofovir/emtricitabine reduces the risk of HIV infection among heterosexuals and serodiscordant couples, researchers reported at IAS 2011.

alt

Read more: